Research Progress on Platelet‐Rich Plasma ( PRP ) in the Treatment of Androgenetic Alopecia
Journal of Cosmetic Dermatology · 2026
DOI: 10.1111/jocd.70809 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cosmetic Dermatology, 2026. Verfasst von Zetian Zhong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Basic Medical Science Department, Zhuhai Campus of Zunyi Medical University, Zhuhai, China. Hauptthemen laut MEDLINE: Alopecia, Platelet-Rich Plasma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Androgenetic alopecia (AGA) is the most common cause of progressive hair loss, significantly affecting quality of life. Current therapies, such as minoxidil, finasteride, and hair transplantation, show variable efficacy and may be associated with adverse effects. Platelet‐rich plasma (PRP), an autologous preparation enriched with platelets and growth factors, has recently gained attention as a regenerative option for hair restoration.
Objective
This review summarizes advances in PRP therapy for AGA, focusing on preparation techniques, mechanisms of action, clinical efficacy, and safety, and provides recommendations for protocol optimization and future research.
Methods
A systematic search of PubMed, Web of Science, Embase, Cochrane Library, and CNKI was conducted for studies published between 2000 and 2025. Eligible articles included randomized controlled trials, cohort studies, case–control studies, and meta‐analyses evaluating PRP preparation methods or therapeutic outcomes. Study quality was appraised using the Cochrane Risk of Bias, ROBINS‐I, and GRADE frameworks.
Results
PRP promotes follicular regeneration through angiogenesis and activation of Wnt/β‐catenin, MAPK, Akt/ERK, and Notch signaling pathways. Clinical trials demonstrate improved hair density, thickness, and patient satisfaction, particularly when PRP is combined with minoxidil, microneedling, or laser therapy. Reported adverse events are mild and transient, such as localized pain or erythema. Nevertheless, heterogeneity in centrifugation, activation, and delivery protocols contributes to inconsistent outcomes across studies.
Conclusion
PRP represents a promising, safe, and minimally invasive therapy for AGA. Establishing standardized preparation protocols and conducting large‐scale randomized studies are essential to confirm long‐term efficacy and integrate PRP into routine, personalized AGA management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Basic Medical Science Department, Zhuhai Campus of Zunyi Medical University, Zhuhai, China.
- Department of Laboratory, the Fifth Affiliated (Zhuhai) Hospital of Zunyi Medical University, Zhuhai, China.
- Department of Dermatology, Doumen District Maternal and Child Health Hospital, Zhuhai, China.
- Department of Transfusion Medicine, the Fifth Affiliated (Zhuhai) Hospital of Zunyi Medical University, Zhuhai, China.
- College of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, China.
ORCID-Profile: Xupeng Yue, Yanxin Lu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhong, Z., Luo, L., Zhao, L., Yue, X., & Lu, Y. (2026). Research Progress on Platelet‐Rich Plasma ( PRP ) in the Treatment of Androgenetic Alopecia. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70809
Vancouver
Zhong Z, Luo L, Zhao L, Yue X, Lu Y. Research Progress on Platelet‐Rich Plasma ( PRP ) in the Treatment of Androgenetic Alopecia. Journal of Cosmetic Dermatology. 2026. doi:10.1111/jocd.70809
BibTeX
@article{Zhong2026,
author = {Zhong, Zetian and Luo, Li and Zhao, Lixiang and Yue, Xupeng and Lu, Yanxin},
title = {Research Progress on Platelet‐Rich Plasma ( PRP ) in the Treatment of Androgenetic Alopecia},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
doi = {10.1111/jocd.70809}
}
EUVIMED